Please login to the form below

Not currently logged in
Email:
Password:

Cardioxyl appoints Novartis scientist as chief medical officer

Shi Yin Foo joins cardiovascular specialist

Cardioxyl Shi Yin Foo Cardioxyl Pharmaceuticals has appointed Novartis' Dr Shi Yin Foo as chief medical officer.

Dr Foo was responsible for the establishment and execution of multiple programmes in heart failure and the cardiorenal space at Novartis and will use her experience to lead research at US-based cardiovascular specialist Cardioxyl.

This experience includes time as a clinical and translational medicine reviewer for numerous studies from phase I to phase III clinical trials.

“Her unique combination of both early- and late-stage cardiovascular development experience combined with her extensive clinical experience in the treatment of patients with heart failure will serve as an excellent complement to Cardioxyl's proprietary expertise in the biology, physiology and chemistry of nitroxyl donors," said Dr Chris Kroeger, Cardioxyl's president and CEO.

Dr Foo spent four years at Novartis from 2009 have joined the pharma company from her role as a physician at Massachusetts General Hospital in the US, where she specialised in cardiology.

16th September 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....
Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...